Sun Yat-sen University: all 1,681 studies

Page 11 of 17. Open to participants first (610), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Somatic Mutation Spectrum as Biomarker for Survival Outcome in Chinese CRCStatus unknownNCT04228614
• Associations Between Vision and Brain FunctionStatus unknownNCT04226729
• Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal CarcinomaActive, not recruitingNCT04223024Phase 2
• Zhaoqing Myopia StudyStatus unknownNCT04219228
• Nail Changes Associated With Chemotherapy and Prevention of Nail Pigmentation by Ice Water ImmersionStatus unknownNCT04215744Not applicable
• DCV in the Treatment of Recurrence and Refractory Childhood Solid TumorsStatus unknownNCT04213612Phase 1
• Development and Validation of a Deep Learning System for Multiple Ocular Fundus Diseases Using Retinal ImagesStatus unknownNCT04213430
• Screening and Identifying Hepatobiliary Diseases Via Deep Learning Using Ocular ImagesCompletedNCT04213183
• Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung CancerStatus unknownNCT04213170Phase 2
• Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung CancerCompletedNCT04212052Phase 2
• Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLCStatus unknownNCT04211090Phase 2
• China Q Cohort StudyStatus unknownNCT04197674
• Neo-TACE-HAIC for PVTT-HCCStatus unknownNCT04181931Not applicable
• Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue SarcomaCompletedNCT04172805Phase 2
• ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBCActive, not recruitingNCT04172259Phase 2
• Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic MetastasisStatus unknownNCT04170179Phase 2
• Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTTStatus unknownNCT04169399Phase 2
• A Study to Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLCStatus unknownNCT04167774Phase 2
• Environmental Health and Myopia Prevention and ControlStatus unknownNCT04161326
• Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial CancerStatus unknownNCT04157491Phase 1/2
• Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT04153799Phase 1
• Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCCStatus unknownNCT04143191Phase 3
• Validation of an Artificial Intelligence System for Postoperative Management of Cataract PatientsStatus unknownNCT04138771Not applicable
• Glaucoma After Congenital And Infantile Cataract SurgeryStatus unknownNCT04131114
• Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal TypeActive, not recruitingNCT04127227Phase 2
• Prospective Comparisons of Clinical Trial and Real-world Outcomes in Nasopharyngeal CarcinomaCompletedNCT04108338
• TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular CarcinomaCompletedNCT04103398Phase 3
• To Explore the Diversity of Intestinal Flora in Patients With Advanced HCC Combin ed With Anti-PD-1 and Targeted Drug Therapy and the Correlation Between Metabolites and Therapeutic EffectStatus unknownNCT04101747
• Biomarkers of Common Eye DiseasesStatus unknownNCT04101604
• The Therapeutic Effect of Dysthyroid Optic NeuropathyStatus unknownNCT04096612Not applicable
• Real World Study of Immune Checkpoint Inhibitors for Advanced Gastric CancerStatus unknownNCT04086888
• Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation TherapyActive, not recruitingNCT04085250Phase 2
• The Efficacy of Immunodetection Point Inhibitors for Advanced Esophageal CancerStatus unknownNCT04074447
• Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.Status unknownNCT04073784Phase 1
• EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)Active, not recruitingNCT04072107Phase 2
• The Outcome and Influence Factors of Assisted Reproductive Therapy in Patients With Cesarean Scar Uterus.Status unknownNCT04070222
• Minocycline Treatment in Retinitis PigmentosaCompletedNCT04068207Phase 2
• Optimal MTX Dose With Folic Acid Randomized Case-control TrialStatus unknownNCT04066803Phase 4
• The Healthy Cantonese Diet on Cardiometabolic SyndromeStatus unknownNCT04064281Not applicable
• Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein OcclusionStatus unknownNCT04062370Phase 4
• The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT04053985Phase 3
• The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.Status unknownNCT04053972Phase 3
• Prediction of the Efficacy of ctDNA in Immunotherapy for Advanced Gastric CancerStatus unknownNCT04053725
• RFA Versus SBRT for Recurrent Small HCCCompletedNCT04047173Phase 3
• Effect of Using Myopia Prediction Algorithm on Myopia School-aged ChildrenStatus unknownNCT04045951Not applicable
• Investigating the Effect of Using Myopia Prediction Algorithm on Myopia ChildrenStatus unknownNCT04044755Not applicable
• Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal CancerStatus unknownNCT04030260Phase 2
• Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLCStatus unknownNCT04028778Phase 3
• Chidamide Combined With Toripalimab in SarcomaCompletedNCT04025931Phase 2
• Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCLCompletedNCT04022005Phase 2
• GVD±R Regimen for ASCT-eligible Patients With Refractory/Relapsed DLBCLStatus unknownNCT04021992Phase 2
• Validation of the Utility of Myopia Intelligent Diagnostic SystemStatus unknownNCT04014725Not applicable
• Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue SarcomaStatus unknownNCT04012827Phase 2
• Effect of Using Myopia Prediction AlgorithmStatus unknownNCT04005014Not applicable
• A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast CancerStatus unknownNCT03997539Phase 2
• Study to Evaluate the Efficacy and Safety of CDK4/6 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast CancerStatus unknownNCT03993964Phase 2
• Nomogram Analysis for HBV Related Acute-on-chronic Liver FailureCompletedNCT03992898
• A Decision Aid for Patients With Age-related CataractStatus unknownNCT03992807Not applicable
• Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver ResectionSuspendedNCT03990974Phase 3
• Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal CarcinomaCompletedNCT03984357Phase 2
• HIV Results Exchange Mechanism on Promoting HIV Testing Among MSMStatus unknownNCT03984136Not applicable
• Perfecting Refraction in India With Superior Service ModelsCompletedNCT03983278Not applicable
• Effect of Probiotics on Blood Pressure ManagementSuspendedNCT03973710Not applicable
• Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With RanibizumabStatus unknownNCT03973138Phase 1/2
• Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal HaemangiomaStatus unknownNCT03973125Early Phase 1
• Effects of Structured Simplified Short-term Intensive Insulin Therapy on Long-term Glycemic RemissionStatus unknownNCT03972982Phase 4
• Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon CancerTerminatedNCT03970694Phase 3
• Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis PatientsStatus unknownNCT03969017Phase 2
• Impact of an Educational Video on Satisfaction After Glaucoma SurgerySuspendedNCT03958929Not applicable
• Effect of Probiotics on Lipid ManagementStatus unknownNCT03952169Not applicable
• JS001 Combined With Regorafenib in Patients With Advanced Colorectal CancerStatus unknownNCT03946917Phase 1/2
• Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCCCompletedNCT03939975Phase 2
• Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell LymphomaCompletedNCT03936452Phase 2
• A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing SpondylitisStatus unknownNCT03932006Phase 4
• Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal CarcinomaActive, not recruitingNCT03930498Phase 2
• Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC PatientsStatus unknownNCT03925896Phase 1
• Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC PatientsActive, not recruitingNCT03925090Phase 2
• No-worry Baby ProjectCompletedNCT03922087
• Phase II of Lenvatinib Plus Toripalimab for Advanced HCCWithdrawnNCT03919383Phase 2
• Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal CancerStatus unknownNCT03912857Phase 2
• IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer PatientsStatus unknownNCT03910634Phase 2
• Effects of Short-term Intensive Insulin Therapy on Long-term Complications in Type 2 DiabetesStatus unknownNCT03909555
• Multi-center Clinical Observation of FCVB in Guangdong ProvinceStatus unknownNCT03908515
• Comparison of the Effect of Minimal Invasive Lens Surgery and Traditional Cataract SurgeryStatus unknownNCT03908359Not applicable
• Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line TherapyCompletedNCT03906058Phase 2
• TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCCStatus unknownNCT03905967Phase 3
• Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver GeneStatus unknownNCT03905317Phase 2
• Bevacizumab After Chemoradiotherapy For Locally Advanced Lung AdenocarcinomaCompletedNCT03904563Phase 2
• A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal CancerStatus unknownNCT03904537Phase 1/2
• A Study of Anti-PD1 Antibody-activated TILs in Non-small Cell Lung CancerStatus unknownNCT03903887Phase 1/2
• Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLCCompletedNCT03900117Phase 2
• RFA vs. SBRT for Small HCCStatus unknownNCT03898921Phase 3
• COmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable Biliary Tract CancerStatus unknownNCT03898895Phase 2
• Anlotinib Maintenance Treatment for Advanced Soft Tissue SarcomaCompletedNCT03890068Phase 2
• HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCCActive, not recruitingNCT03869034Phase 2
• Evaluation of a Smart Phone App-based Case Management Model Among ART-naive HIV-infected MSMStatus unknownNCT03860116Not applicable
• Serial Epstein-Barr Virus DNA Surveillance in Nasopharyngeal Carcinoma PatientsActive, not recruitingNCT03855020
• IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.Status unknownNCT03854838Phase 2
• The Efficacy of Transarterial Chemoinfusion (TAI) Combine Toripalimab in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT03851939Phase 2
• The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent HepatectomyStatus unknownNCT03851913Phase 3

← Sun Yat-sen University overview and focus areas